Skip to main content

Table 1 Baseline characteristics of the study population (number of patients).

From: Recursive partitioning analysis of prognostic factors in WHO grade III glioma patients treated with radiotherapy or radiotherapy plus chemotherapy

 

AA

AO

AOA

Total

 

(n = 56)

(n = 67)

(n = 10)

(n = 133)

Age at diagnosis

    

   ≥50 years

16 (28.6%)

17 (25.4%)

3 (30.0%)

36 (27.1%)

   < 50 years

40 (71.4%)

50 (74.6%)

7 (70.0%)

97 (72.9%)

Performance status

    

   ECOG grade 0

5 (8.9%)

10 (14.9%)

2 (20.0%)

17 (12.8%)

   ECOG grade 1

38 (67.8%)

44 (65.7%)

5 (50.0%)

87 (65.4%)

   ECOG grade 2

9 (16.1%)

7 (10.4%)

0

16 (12.0%)

   ECOG grade 3

2 (3.6%)

5 (7.5%)

3 (30.0%)

10 (7.5%)

   ECOG grade 4

2 (3.6%)

1 (1.5%)

0

3 (2.3%)

Extent of resection

    

   complete

6 (10.7%)

27 (40.3%)

3 (30.0%)

36 (27.1%)

   incomplete

50 (89.3%)

40 (59.7%)

7 (70.0%)

97 (72.9%)

Baseline treatment

    

   radiotherapy

31 (55.3%)

31 (46.3%)

5 (50.0%)

67 (50.3%)

   radiotherapy plus PCV**

25 (44.7%)

36 (53.7%)

5 (50.0%)

66 (49.7%)

  1. ECOG: Eastern Cooperative Oncology Group
  2. PCV: procarbazine, lomustine, and vincristine